TriLipidermBroad Spectrum SPF 30 (TriLipid Research Institute, LLC)


Welcome to the PulseAid listing for the TriLipiderm drug offered from TriLipid Research Institute, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: TriLipid Research Institute, LLC
NON-PROPRIETARY NAME: Butyl Methoxydibenzoylmethane, Ethylhexyl methoxycinnamate, Homosalate, Octocrylene
SUBSTANCE NAME: AVOBENZONE; OCTINOXATE; HOMOSALATE; OCTOCRYLENE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2014-01-31
END MARKETING DATE: 0000-00-00


TriLipiderm Broad Spectrum SPF 30 HUMAN OTC DRUG Details:

Item DescriptionTriLipiderm Broad Spectrum SPF 30 from TriLipid Research Institute, LLC
LABELER NAME: TriLipid Research Institute, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 7.5; 10; 2.7(g/100mL; g/100mL; g/100mL; g/100mL)
START MARKETING DATE: 2014-01-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60892-601_f290a608-92ee-49e0-957e-b67f1006f489
PRODUCT NDC: 60892-601
APPLICATION NUMBER: part352

Other AVOBENZONE; OCTINOXATE; HOMOSALATE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
TriLipid Research Institute, LLCTriLipiderm